Lebenthal Global Advisors LLC Acquires New Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Lebenthal Global Advisors LLC purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 12,681 shares of the company's stock, valued at approximately $991,000.

Other hedge funds have also recently made changes to their positions in the company. LGT Financial Advisors LLC boosted its position in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 251 shares during the period. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies in the 3rd quarter worth $26,000. Ashton Thomas Securities LLC purchased a new stake in GE HealthCare Technologies in the 3rd quarter worth $26,000. Darwin Wealth Management LLC bought a new stake in GE HealthCare Technologies during the third quarter valued at about $31,000. Finally, Continuum Advisory LLC lifted its position in shares of GE HealthCare Technologies by 101.8% in the third quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 1.4 %

GE HealthCare Technologies stock traded down $1.25 during midday trading on Friday, reaching $88.30. The stock had a trading volume of 1,774,292 shares, compared to its average volume of 2,699,807. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a market cap of $40.34 billion, a price-to-earnings ratio of 24.26, a price-to-earnings-growth ratio of 2.90 and a beta of 1.11. GE HealthCare Technologies Inc. has a 52-week low of $72.52 and a 52-week high of $94.55. The company has a fifty day moving average of $82.76 and a 200 day moving average of $84.95.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The firm had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. During the same period last year, the company earned $0.99 EPS. GE HealthCare Technologies's quarterly revenue was up .9% compared to the same quarter last year. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.03. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.85%.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Roland Rott sold 3,577 shares of the company's stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at approximately $2,101,291.04. This represents a 12.83 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.27% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Jefferies Financial Group raised GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a report on Thursday, October 31st. One analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $96.00.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.